Quant snapshot: J. Jill, AngioDynamics leads strong buys as INmune Bio, Terrestrial Energy lag
Source: SeekingAlpha
2026-03-29 09:30:20 ET
More on J. Jill, AngioDynamics, etc.
- Nike At 5-Year Lows: Why The Turnaround Is Already Working
- Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases
- Tilray: Big Bet On Beverages (Rating Upgrade)
- Beyond Meat Q4 2025 Earnings Preview
- Jefferies likes these consumer stocks if the Iran conflict is resolved
Read the full article on Seeking Alpha
For further details see:
Quant snapshot: J. Jill, AngioDynamics leads strong buys as INmune Bio, Terrestrial Energy lag
INmune Bio Inc.
NASDAQ: INMB
INMB Trading
-5.14% G/L:
$1.57 Last:
245,179 Volume:
$1.66 Open:
INMB Latest News
May 15, 2026 08:00:00 am
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro(TM) PlatformMay 14, 2026 08:00:00 am
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's DiseaseINMB Stock Data
$100,001,939
20,608,626
3.69%
19
N/A
Biotechnology & Life Sciences
Healthcare
US
Boca Raton
